@article{article, title  = {{Additional efficacy and safety outcomes and an exploratory analysis of the impact of pathological complete response (pCR) on long-term outcomes from NIAGARA.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{https://doi.org/10.1200/jco.2025.43.5_suppl.659 }},

 year = {{2025}},

 month = {{2}},

 author = {{Galsky MD and Van Der Heijden MS and Catto JWF and Al-Ahmadie H and Meeks JJ and Nishiyama H and Drakaki A and Vu TQ and Antonuzzo L and Atduev V and Kann AG et al}},

 doi = {{10.1200/jco.2025.43.5_suppl.659}},

 volume = {{43}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{5_suppl}},

 pages = {{659-659}},

 note = {{Accessed on 2025/04/05}}}